Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28834538 | 0.84 | TSHR (0.44) | TSHRSMN1; SMN2 | |
| SCHEMBL11804936 | 0.82 | TSHR (0.41) | TSHRSMN1; SMN2LMNA | |
| SCHEMBL2213674 | 0.82 | TSHR (0.45) | TSHRSMN1; SMN2LMNA | |
| SCHEMBL10490298 | 0.80 | TSHR (0.41) | TSHRSMN1; SMN2 | |
| SCHEMBL17336085 | 0.80 | TSHR (0.41) | TSHRSMN1; SMN2 | |
| SCHEMBL17336097 | 0.80 | TSHR (0.41) | TSHRSMN1; SMN2 | |
| SCHEMBL7066232 | 0.80 | TSHR (0.41) | TSHRSMN1; SMN2 | |
| SCHEMBL11246678 | 0.80 | TSHR (0.41) | TSHRSMN1; SMN2 | |
| SCHEMBL10348951 | 0.79 | TSHR (0.38) | TSHRSMN1; SMN2LMNA | |
| SCHEMBL3267922 | 0.77 | LMNA (0.35) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6603033-B2 | Used as sources of titanium dioxide for metal-organic chemical vapor deposition (MOCVD) | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-08-05 | — | — | US | disclosed |
| US-20030040638-A1 | Organotitanium precursors for chemical vapor deposition and manufacturing method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040638-A1 | Organotitanium precursors for chemical vapor deposition and manufacturing method thereof | TKT, ADH5, KYAT1 | TSHR 1233/4885SMN1; SMN2 3346/4885LMNA 4695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.